These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27591073)

  • 1. Pramipexole-associated fixed limb dystonia in Parkinson's disease.
    Pandey S; Jain S
    Parkinsonism Relat Disord; 2016 Oct; 31():159-160. PubMed ID: 27591073
    [No Abstract]   [Full Text] [Related]  

  • 2. Pramipexole-induced limb dystonia and its associated complex regional pain syndrome in idiopathic Parkinson's disease: A case report.
    Park D
    Medicine (Baltimore); 2017 Jul; 96(28):e7530. PubMed ID: 28700507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pramipexole and gender identity disorder: expanding the phenotype of hypersexuality in Parkinson's disease.
    Odiyoor M; Kobylecki C; Hackett RJ; Silverdale MA; Kellett MW
    Mov Disord; 2009 Dec; 24(16):2434-5. PubMed ID: 19891000
    [No Abstract]   [Full Text] [Related]  

  • 4. Pramipexole for depression and motor symptoms in Parkinson's disease: can we kill two birds with one stone?
    Fernandez HH; Merello M
    Lancet Neurol; 2010 Jun; 9(6):556-7. PubMed ID: 20452824
    [No Abstract]   [Full Text] [Related]  

  • 5. Pramipexole reduces the prevalence of fatigue in patients with Parkinson's disease.
    Morita A; Okuma Y; Kamei S; Yoshii F; Yamamoto T; Hashimoto S; Utsumi H; Hatano T; Hattori N; Matsumura M; Takahashi K; Nogawa S; Watanabe Y; Miyamoto T; Miyamoto M; Hirata K
    Intern Med; 2011; 50(19):2163-8. PubMed ID: 21963735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of pramipexole on depressive symptoms in Parkinson's disease.
    Yasui N; Sekiguchi K; Hamaguchi H; Kanda F
    Kobe J Med Sci; 2011 Feb; 56(5):E214-9. PubMed ID: 21937869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful pregnancy and delivery in a patient with Parkinson's disease under pramipexole treatment.
    Benbir G; Ertan S; Ozekmekci S
    Presse Med; 2014 Jan; 43(1):83-5. PubMed ID: 23688703
    [No Abstract]   [Full Text] [Related]  

  • 8. Reversible Pisa syndrome in Parkinson's disease during treatment with pergolide: a case report.
    Cannas A; Solla P; Floris G; Borghero G; Tacconi P; Spissu A
    Clin Neuropharmacol; 2005; 28(5):252. PubMed ID: 16239770
    [No Abstract]   [Full Text] [Related]  

  • 9. Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
    Barone P; Poewe W; Albrecht S; Debieuvre C; Massey D; Rascol O; Tolosa E; Weintraub D
    Lancet Neurol; 2010 Jun; 9(6):573-80. PubMed ID: 20452823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two cases of pregnancy in Parkinson's disease.
    Lamichhane D; Narayanan NS; Gonzalez-Alegre P
    Parkinsonism Relat Disord; 2014 Feb; 20(2):239-40. PubMed ID: 24182521
    [No Abstract]   [Full Text] [Related]  

  • 11. Telogen effluvium associated with the dopamine agonist pramipexole in a 55-year-old woman with Parkinson's disease.
    Katz KA; Cotsarelis G; Gupta R; Seykora JT
    J Am Acad Dermatol; 2006 Nov; 55(5 Suppl):S103-4. PubMed ID: 17052518
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pathological gambling associated with pramipexole use in Parkinson's disease].
    Lester J; Gonzalez-Aleman G; Zuniga-Ramirez C; Diaz-Pascuali SP; Raina-Castellino GB; Micheli-Gould F
    Rev Neurol; 2006 Sep 1-15; 43(5):316-8. PubMed ID: 16941434
    [No Abstract]   [Full Text] [Related]  

  • 13. Lingual protrusion dystonia: Manifestation during "on" periods in Parkinson's disease.
    Maiola R; Ramirez Gómez CC; Micheli F
    J Neurol Sci; 2016 Nov; 370():256-257. PubMed ID: 27772770
    [No Abstract]   [Full Text] [Related]  

  • 14. Pramipexole-induced psychosis in Parkinson's disease.
    Li CT; Tsai SJ; Hwang JP
    Psychiatry Clin Neurosci; 2008 Apr; 62(2):245. PubMed ID: 18412854
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pramipexole and Parkinson's disease, an update].
    Martínez-Corral M; Kulisevsky J
    Rev Neurol; 2008 Jan 1-15; 46(1):49-52. PubMed ID: 18214827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 77-year-old man with Parkinson's disease and hyperthermia.
    Madigan EJ
    J Emerg Nurs; 2008 Jun; 34(3):229-30. PubMed ID: 18558256
    [No Abstract]   [Full Text] [Related]  

  • 17. Pramipexole extended release: in Parkinson's disease.
    Chwieduk CM; Curran MP
    CNS Drugs; 2010 Apr; 24(4):327-36. PubMed ID: 20297857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pramipexole marketed for Parkinson's disease.
    Am J Health Syst Pharm; 1997 Sep; 54(17):1922. PubMed ID: 9290885
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost effectiveness of rasagiline and pramipexole as treatment strategies in early Parkinson's disease in the UK setting: An economic Markov model evaluation.
    Kovacs N; Janszky J; Nagy F
    Drugs Aging; 2011 Feb; 28(2):161-2. PubMed ID: 21275441
    [No Abstract]   [Full Text] [Related]  

  • 20. PROUD stands tall: delayed-start studies in Parkinson's disease.
    Hauser RA
    Lancet Neurol; 2013 Aug; 12(8):728-9. PubMed ID: 23726852
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.